Diabetic Ketoacidosis in A Patient with Type 2 Diabetes On Canagliflozin and Dexamethasone

ABSTRACT: Objective: To describe a case of diabetic ketoacidosis (DKA) associated with sodium-glucose cotransporter-2 inhibitor (SGLT2i) and dexamethasone use in a patient with type 2 diabetes.Methods: We present the case of an 87-year-old male with type 2 diabetes on canagliflozin who underwent res...

Full description

Bibliographic Details
Main Authors: Lisa D. Alexander, MD, Catherine Yu, MD, FRCPC, MHSc
Format: Article
Language:English
Published: Elsevier 2017-01-01
Series:AACE Clinical Case Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S237606052030420X